Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.

• Status: Completed
• Trial end date: 2015-05-31
• Target enrollment: 0
• Participant gender: Male

Summary

A bio-equivalence of 2 different capsule formulations in fasted subjects

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Tamsulosin

Criteria

Inclusion criteria:

Healthy male volunteers 18 years and older

Exclusion criteria:

History of hypersensitivity or allergy to the IPM or its excipients or any related medication